Azitra, Inc. (AZTR)
0.7425
+0.02
(+2.40%)
USD |
NYAM |
Nov 06, 10:27
Azitra EPS Diluted (Quarterly) : -1.734 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.734 |
| March 31, 2026 | -2.531 |
| December 31, 2025 | -2.080 |
| September 30, 2025 | -6.714 |
| June 30, 2025 | -11.82 |
| March 31, 2025 | -15.51 |
| December 31, 2024 | -20.90 |
| September 30, 2024 | -11.56 |
| Date | Value |
|---|---|
| June 30, 2024 | -182.56 |
| March 31, 2024 | -287.71 |
| December 31, 2023 | -405.25 |
| September 30, 2023 | -320.94 |
| June 30, 2023 | -837.80 |
| March 31, 2023 | -523.90 |
| June 30, 2022 | -426.49 |
| March 31, 2022 | -498.94 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 0.00 |
| Exicure, Inc. | -0.1759 |
| Century Therapeutics, Inc. | -0.1679 |
| Absci Corp. | -0.2109 |
| Celularity, Inc. | 0.0186 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.348M |
| Total Expenses (Quarterly) | 3.348M |
| Enterprise Value | -1.923M |
| Earnings Yield | -1.76K% |
| Normalized Earnings Yield | -1758.75 |